Which hedge funds own UTHR? UNITED THERAPEUTICS CORP DEL, Q2 2026 13F holders
Healthcare · Open on the interactive board
12 of the hedge funds tracked by WhaleCreep disclosed a position in UTHR (UNITED THERAPEUTICS CORP DEL) in their Q2 2026 13F filings, worth $1.9bn in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 1.3% of its book. 2 managers opened a new position this quarter: Brevan Howard Capital Management, Tudor Investment. 1 exited: D. E. Shaw & Co.
12tracked managers holding
2opened this quarter
1exited this quarter
Which hedge funds hold UTHR? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 1.3% | $925.8m | 1,708,739 | -4% | reduced |
| Baillie Gifford | Q2 2026 | 0.4% | $398.0m | 467,209 | 9% | added |
| Bridgewater Associates | Q2 2026 | 0.2% | $60.3m | 111,326 | 0% | held |
| Point72 Asset Management LP | Q2 2026 | 0.2% | $109.0m | 201,159 | 35% | added |
| Millennium Management | Q2 2026 | 0.1% | $221.6m | 409,074 | 167% | added |
| Citadel Advisors | Q2 2026 | 0.1% | $165.1m | 304,692 | -16% | reduced |
| Woodline Partners | Q2 2026 | 0.0% | $12.5m | 23,074 | 564% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $2.3m | 4,174 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $6.9m | 12,667 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $16.4m | 30,231 | -60% | reduced |
| Holocene Advisors | Q2 2026 | 0.0% | $844.7k | 1,559 | 0% | held |
| Ancora Advisors | Q2 2026 | 0.0% | $5.4k | 10 | 0% | held |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| D. E. Shaw & Co | 1.3% | $58.8m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Caxton Associates | Q4 2024 | 0.0% |
How has hedge fund ownership of UTHR changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 12 | $1.9bn |
| Q1 2026 | 11 | $1.8bn |
| Q4 2025 | 9 | $1.2bn |
| Q3 2025 | 7 | $996.6m |
| Q2 2025 | 4 | $666.0m |
| Q1 2025 | 5 | $715.2m |
| Q4 2024 | 5 | $784.0m |
| Q3 2024 | 5 | $799.9m |
| Q2 2024 | 5 | $780.4m |
| Q1 2024 | 6 | $608.9m |
| Q4 2023 | 8 | $665.0m |
| Q3 2023 | 7 | $549.2m |
| Q2 2023 | 7 | $591.6m |
| Q1 2023 | 6 | $703.5m |
| Q4 2022 | 5 | $1.1bn |
| Q3 2022 | 6 | $918.7m |
Counts every tracked manager that disclosed UTHR in that quarter's filing, including managers that have since stopped filing.